Medical Use
Xospata is a kinase inhibitor prescribed for adult patients with relapsed or refractory acute myeloid leukemia (AML) that has a FLT3 mutation.
Recommended Dosage: The starting dose is 120 mg taken orally once daily, with or without food. To achieve a clinical response, it is recommended to continue treatment for at least six months, provided there is no disease progression or unacceptable toxicity.
Administration Instructions: Swallow the tablets whole; do not break or crush them. Take the medication consistently at the same time each day. If you miss a dose or do not take it at the usual time, take it as soon as possible on the same day, ensuring it is at least 12 hours before the next scheduled dose. Resume the regular dosing schedule the following day. Do not take two doses within a 12-hour period.
Warning & Precautions
Monitoring Requirements: Before starting Xospata 40 mg, evaluate blood counts and blood chemistries, including creatine phosphokinase. Continue monitoring at least weekly during the first month, every other week during the second month, and monthly thereafter.
Cardiac Monitoring: Gilteritinib can prolong the QT interval, affecting cardiac ventricular repolarization. Perform an ECG before starting treatment, on days 8 and 15 of the first cycle, and before starting the next two cycles.
Electrolyte Management: Hypokalemia and hypomagnesemia can increase the risk of QT prolongation. Correct these electrolyte imbalances before and during treatment.
Pancreatitis Risk: Patients on Xospata 40 mg may develop pancreatitis. Monitor for signs and symptoms, and if pancreatitis occurs, interrupt and reduce the dose.
Embryo-Fetal Risk: Gilteritinib can cause harm to a fetus. Women of reproductive age should use effective contraception during treatment and for at least six months after the last dose.
Breastfeeding: Breastfeeding is not recommended during treatment and for at least two months after the final dose due to the potential for serious side effects in the breastfed child.
Documentation Availability
Documents required to import XOSPATA to India?
XOSPATA (Gilteritinib) tablets can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing XOSPATA (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
Who manufactures Xospata®?
Xospata® is manufactured by Astellas Pharma US, Inc.
Is Xospata® FDA approved?
Yes, Xospata® was approved by the FDA on November 28, 2018.
What is the dosage and form of Xospata®?
Xospata® is available as 40 mg tablets for oral administration.
Who should not take Xospata®?
Do not take Xospata® if you are allergic to gilteritinib or any of its ingredients.
What are the most common side effects of Xospata®?
Common side effects include fever, increased transaminase levels, fatigue, mucositis, rash, edema, noninfectious diarrhea, shortness of breath, nausea, cough, constipation, eye disorders, renal impairment, headache, dizziness, low blood pressure, and vomiting.
How much does Xospata® cost in India?
The cost of Xospata® in India is reasonable and can vary. For authentic procurement, you can reach out to Rx4u team.
What are the storage conditions for Xospata®?
Store Xospata® tablets at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the tablets in their original container until dispensed, and protect them from light, moisture, and humidity.
Is it safe to buy Xospata® online in India?
Yes, you can safely purchase Xospata® online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
